| Dr Carter Bolton Freiburg, MD | |
|
520 Upper Chesapeake Dr, Suite 306 Ambulatory Care Center, Bel Air, MD 21014-4339 | |
| (410) 879-2006 | |
| (410) 420-2006 |
| Full Name | Dr Carter Bolton Freiburg |
|---|---|
| Gender | Male |
| Speciality | Vascular Surgery |
| Experience | 21 Years |
| Location | 520 Upper Chesapeake Dr, Bel Air, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720102288 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | BF4323200SW (Vermont) | Primary |
| 2086S0129X | Surgery - Vascular Surgery | D0071822 (Maryland) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Carroll Hospital Center | Westminster, MD | Hospital |
| Greater Baltimore Medical Center | Baltimore, MD | Hospital |
| Sinai Hospital Of Baltimore | Baltimore, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lifebridge Sports Medicine And Rehabilitation Llc | 4385787910 | 210 |
| Vascular Surgery Associates Llc | 3173500410 | 19 |
News Archive
ARIAD Pharmaceuticals, Inc. today announced updated clinical data from an ongoing Phase 1 study of its investigational pan-BCR-ABL inhibitor, AP24534, in patients with resistant and refractory chronic myeloid leukemia (CML). The data confirm strong clinical evidence of hematologic, cytogenetic and molecular anti-leukemia activity of AP24534, a multi-targeted kinase inhibitor, in heavily pretreated patients with CML, including those with the T315I mutation of the target protein, BCR-ABL.
A new study finding suggested this Tuesday that it is a myth that freshmen gain an average of 15 pounds in their first year of school. The average is really between 2.4 pounds for women and 3.4 pounds for men.
New Colombia Resources, Inc., a U.S. company with coal and other resource assets in Colombia, is pleased to announce an agreement of collaboration with the Phoenix Tears Foundation for the research and development of a cannabis based medicine to treat skin cancer in Colombia.
Workflow automation technology provider, Clarifire, announced today two pilots of its new product CLARIFIRE HEALTH. The pilots, performed in partnership with one of the largest Florida healthcare providers, will test intake processes and associated workflow as well as a mobile app that will be used by nurse managers when rounding with patients. Both pilots are designed to standardize patient care and improve patient satisfaction, risk management, and compliance.
› Verified 5 days ago
| Entity Name | Vascular Surgery Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548222912 PECOS PAC ID: 3173500410 Enrollment ID: O20040702001170 |
News Archive
ARIAD Pharmaceuticals, Inc. today announced updated clinical data from an ongoing Phase 1 study of its investigational pan-BCR-ABL inhibitor, AP24534, in patients with resistant and refractory chronic myeloid leukemia (CML). The data confirm strong clinical evidence of hematologic, cytogenetic and molecular anti-leukemia activity of AP24534, a multi-targeted kinase inhibitor, in heavily pretreated patients with CML, including those with the T315I mutation of the target protein, BCR-ABL.
A new study finding suggested this Tuesday that it is a myth that freshmen gain an average of 15 pounds in their first year of school. The average is really between 2.4 pounds for women and 3.4 pounds for men.
New Colombia Resources, Inc., a U.S. company with coal and other resource assets in Colombia, is pleased to announce an agreement of collaboration with the Phoenix Tears Foundation for the research and development of a cannabis based medicine to treat skin cancer in Colombia.
Workflow automation technology provider, Clarifire, announced today two pilots of its new product CLARIFIRE HEALTH. The pilots, performed in partnership with one of the largest Florida healthcare providers, will test intake processes and associated workflow as well as a mobile app that will be used by nurse managers when rounding with patients. Both pilots are designed to standardize patient care and improve patient satisfaction, risk management, and compliance.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Carter Bolton Freiburg, MD 520 Upper Chesapeake Dr, Suite 306 Ambulatory Care Center, Bel Air, MD 21014-4339 Ph: (410) 879-2006 | Dr Carter Bolton Freiburg, MD 520 Upper Chesapeake Dr, Suite 306 Ambulatory Care Center, Bel Air, MD 21014-4339 Ph: (410) 879-2006 |
News Archive
ARIAD Pharmaceuticals, Inc. today announced updated clinical data from an ongoing Phase 1 study of its investigational pan-BCR-ABL inhibitor, AP24534, in patients with resistant and refractory chronic myeloid leukemia (CML). The data confirm strong clinical evidence of hematologic, cytogenetic and molecular anti-leukemia activity of AP24534, a multi-targeted kinase inhibitor, in heavily pretreated patients with CML, including those with the T315I mutation of the target protein, BCR-ABL.
A new study finding suggested this Tuesday that it is a myth that freshmen gain an average of 15 pounds in their first year of school. The average is really between 2.4 pounds for women and 3.4 pounds for men.
New Colombia Resources, Inc., a U.S. company with coal and other resource assets in Colombia, is pleased to announce an agreement of collaboration with the Phoenix Tears Foundation for the research and development of a cannabis based medicine to treat skin cancer in Colombia.
Workflow automation technology provider, Clarifire, announced today two pilots of its new product CLARIFIRE HEALTH. The pilots, performed in partnership with one of the largest Florida healthcare providers, will test intake processes and associated workflow as well as a mobile app that will be used by nurse managers when rounding with patients. Both pilots are designed to standardize patient care and improve patient satisfaction, risk management, and compliance.
› Verified 5 days ago
Dr. David Marshall Lanphear, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 2515 Fairway Dr., Bel Air, MD 21015 Phone: 410-836-5016 | |
Dr. Peter J Mackrell, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 520 Upper Chesapeake Dr, Suite 306, Bel Air, MD 21014 Phone: 410-879-2006 Fax: 410-879-0248 | |
Philip Andrew Rivera, MD Surgery Medicare: Medicare Enrolled Practice Location: 520 Upper Chesapeake Dr Ste 306, Bel Air, MD 21014 Phone: 410-879-2006 | |
Andre Biuckians, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 520 Upper Chesapeake Dr, Suite 306, Bel Air, MD 21014 Phone: 617-512-7277 | |
Dr. Richard A Bafford, MD, MSPH Surgery Medicare: Accepting Medicare Assignments Practice Location: 520 Upper Chesapeake Dr, Suite 306, Bel Air, MD 21014 Phone: 410-879-2006 | |
Dr. Mathew A. Thomas, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 2012 S Tollgate Rd, Suite 100, Bel Air, MD 21015 Phone: 410-569-5155 Fax: 410-569-5166 | |
Dr. Roger E Schneider, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 520 Upper Chesapeake Dr, Suite 306, Bel Air, MD 21014 Phone: 410-879-2006 Fax: 410-879-0248 |